Clinical trial
Relationship Between Dopaminergic Asymmetric Degeneration and Attentional Resources in Parkinson's Disease.
NCT03476668 is registered in ClinicalTrials.gov with Ospedale Generale Di Zona Moriggia-Pelascini as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Relationship Between Dopaminergic Asymmetric Degeneration and Attentional Resources in Parkinson's Disease.
- Lead sponsor
- Ospedale Generale Di Zona Moriggia-Pelascini
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 1, 2017
- Completion date
- August 1, 2017
- Enrollment
- 100 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
attention disturbances, parkinson disease